Bivalirudin: role in current percutaneous coronary intervention practice

被引:1
|
作者
West, N [1 ]
机构
[1] Gloucestershire Hosp NHS Fdn Trust, Gloucester GL1 3NN, England
[2] John Radcliffe Hosp, Oxford OX3 9DU, England
关键词
D O I
10.12968/hmed.2005.66.12.20208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bivalirudin is the only thrombin-specific anticoagulant currently licensed in the UK for use as an anticoagulant during percutaneous coronary intervention. This review examines the rationale for, and data supporting, its use in contemporary percutaneous coronary intervention practice.
引用
收藏
页码:687 / 689
页数:3
相关论文
共 50 条
  • [41] Prolonged bivalirudin infusion post percutaneous coronary intervention and risk of bleeding
    Lombo, Bernardo
    Ibrahim, Homan
    Lievano, Marta
    Diez, Jose
    Fish, David
    CIRCULATION, 2012, 125 (19) : E868 - E868
  • [42] Bivalirudin - A review of its use in patients undergoing percutaneous coronary intervention
    Moen, MD
    Keating, GM
    Wellington, K
    DRUGS, 2005, 65 (13) : 1869 - 1891
  • [43] SAFETY AND OUTCOMES OF BIVALIRUDIN IN DIALYSIS PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Delhaye, Cedric
    Maluenda, Gabriel
    Wakabayashi, Kohei
    Ben-Dor, Itsik
    Collins, Sara D.
    Syed, Asmir I.
    Gonzalez, Manuel A.
    Gaglia, Michael A.
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [44] Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention
    Lemesle, Gilles
    Bonello, Laurent
    De Labriolle, Axel
    Steinberg, Daniel H.
    Roy, Probal
    Slottow, Tina L. Pinto
    Torguson, Rebecca
    Kaneshige, Kimberly
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2009, 22 (01) : 61 - 67
  • [45] The emerging role of thrombus aspiration in contemporary percutaneous coronary intervention practice
    W. G. Wieringa
    F. Zijlstra
    Netherlands Heart Journal, 2010, 18 : 400 - 401
  • [46] The emerging role of thrombus aspiration in contemporary percutaneous coronary intervention practice
    Wieringa, W. G.
    Zijlstra, F.
    NETHERLANDS HEART JOURNAL, 2010, 18 (09): : 400 - 401
  • [47] Aspirin desensitization in patients undergoing percutaneous coronary intervention: A survey of current practice
    Chapman, Andrew R.
    Rushworth, Gordon F.
    Leslie, Stephen J.
    CARDIOLOGY JOURNAL, 2013, 20 (02) : 134 - 138
  • [48] Percutaneous coronary intervention-related bleeding risk factors in current practice
    Mathis, AS
    Gugger, JJ
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) : 1627 - 1633
  • [49] Preprocedural Dual Antiplatelet Therapy for Percutaneous Coronary Intervention in Japanese Current Practice
    Furukawa, Yutaka
    CIRCULATION JOURNAL, 2015, 79 (12) : 2544 - 2546
  • [50] Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention
    MacHaalany, Jimmy
    Abdelaal, Eltigani
    Bataille, Yoann
    Plourde, Guillaume
    Duranleau-Gagnon, Pierre
    Larose, Eric
    Dery, Jean-Pierre
    Barbeau, Gerald
    Rinfret, Stephane
    Rodes-Cabau, Josep
    De Larochelliere, Robert
    Roy, Louis
    Costerousse, Olivier
    Bertrand, Olivier F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12): : 1742 - 1748